$0
$260,000
0.0% of portfolio
21,086
Q1 2025
Reduced 98.77%
$0
$518,000
0.0% of portfolio
50,194
Q1 2025
Reduced 98.97%
$0
$254,000
0.0% of portfolio
14,440
Q1 2025
Reduced 98.24%
$0
$3,000
0.0% of portfolio
602
Q1 2025
Reduced 99.5%
$2.5B
$222,000
0.0% of portfolio
15,884
Q1 2025
Reduced 98.6%
$857M
$381,000
0.0% of portfolio
12,466
Q1 2025
Reduced 96.94%
$0
$136,000
0.0% of portfolio
5,524
Q1 2025
Reduced 97.54%
Spire Global Inc Com Cl A New
-
$88,000
0.0% of portfolio
-
Q1 2025
Reduced 87.64%
$4.01B
$727,000
0.0% of portfolio
56,888
Q1 2025
Reduced 98.72%
$3.46B
$320,000
0.0% of portfolio
11,027
Q1 2025
Reduced 97.1%
$303M
$600,000
0.0% of portfolio
9,864
Q1 2025
Reduced 93.92%
$2.34B
$303,000
0.0% of portfolio
13,371
Q1 2025
Reduced 97.73%
$909M
$410,000
0.0% of portfolio
9,016
Q1 2025
Reduced 95.45%
$4.69B
$448,000
0.0% of portfolio
59,463
Q1 2025
Reduced 99.25%
Spyre Therapeutics Inc Com New
-
$270,000
0.0% of portfolio
-
Q1 2025
Reduced 93.8%
$830M
$831,000
0.0% of portfolio
14,651
Q1 2025
Reduced 94.33%
$5.75B
$919,000
0.0% of portfolio
33,194
Q1 2025
Reduced 97.23%
$698M
$11,000
0.0% of portfolio
67
Q1 2025
Reduced 83.58%
$1.71B
$202,000
0.0% of portfolio
32,601
Q1 2025
Reduced 99.38%
$1.46B
$200,000
0.0% of portfolio
3,112
Q1 2025
Reduced 93.57%
-
$269,000
0.0% of portfolio
-
Q1 2025
Reduced 88.25%
$944M
$521,000
0.0% of portfolio
5,710
Q1 2025
Reduced 90.88%
$30.1B
$280,000
0.0% of portfolio
3,139
Q1 2025
Reduced 91.08%
$1.07B
$261,000
0.0% of portfolio
14,365
Q1 2025
Reduced 98.18%
$4.1B
$307,000
0.0% of portfolio
34,755
Q1 2025
Reduced 99.12%
$5.92B
$10,000
0.0% of portfolio
204
Q1 2025
Reduced 95.1%
$1.81B
$388,000
0.0% of portfolio
27,684
Q1 2025
Reduced 98.6%
$264M
$331,000
0.0% of portfolio
1,076
Q1 2025
Reduced 69.24%
$1.9B
$323,000
0.0% of portfolio
22,306
Q1 2025
Reduced 98.55%
$298M
$806,000
0.0% of portfolio
5,360
Q1 2025
Reduced 84.96%
$1.6B
$742,000
0.0% of portfolio
56,674
Q1 2025
Reduced 98.69%
$1.9B
$133,000
0.0% of portfolio
11,167
Q1 2025
Reduced 98.81%
$157M
$192,000
0.0% of portfolio
3,408
Q1 2025
Reduced 94.37%
$64.9M
$254,000
0.0% of portfolio
3,025
Q1 2025
Reduced 91.6%
Structure Therapeutics Inc Sponsored Ads
-
$507,000
0.0% of portfolio
-
Q1 2025
Reduced 94.22%
$732M
$653,000
0.0% of portfolio
25,656
Q1 2025
Reduced 97.45%
$5.26B
$825,000
0.0% of portfolio
15,914
Q1 2025
Reduced 94.82%
$563M
$802,000
0.0% of portfolio
9,881
Q1 2025
Reduced 91.88%
$33.2B
$576,000
0.0% of portfolio
32,982
Q1 2025
Reduced 98.25%
$45.7B
$155,000
0.0% of portfolio
6,002
Q1 2025
Reduced 97.42%
$442M
$290,000
0.0% of portfolio
1,409
Q1 2025
Reduced 79.42%
Sunrise Communications Ag Ads Cl A
-
$53,000
0.0% of portfolio
-
Q1 2025
Reduced 97.93%
-
$73,000
0.0% of portfolio
-
Q1 2025
Reduced 90.97%
$3.56B
$665,000
0.0% of portfolio
4,283
Q1 2025
Reduced 84.47%
$169M
$124,000
0.0% of portfolio
1,357
Q1 2025
Reduced 90.86%
$1.92B
$374,000
0.0% of portfolio
8,883
Q1 2025
Reduced 95.79%
$2.04B
$423,000
0.0% of portfolio
10,583
Q1 2025
Reduced 96.0%
$34.1B
$191,000
0.0% of portfolio
1,690
Q1 2025
Reduced 88.7%
$231M
$195,000
0.0% of portfolio
3,391
Q1 2025
Reduced 94.25%
$2.64B
$450,000
0.0% of portfolio
30,182
Q1 2025
Reduced 98.51%